Published in J Asthma on January 01, 1996
Inhaled corticosteroids in asthma--star wars. J Asthma (1996) 0.75
Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) (1982) 7.77
Oxygen relieves breathlessness in "pink puffers". Lancet (1981) 3.64
Pulmonary fibrosis associated with hypersensitivity to gold salts. Br Med J (1976) 2.91
Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med (1977) 2.83
The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest (1979) 2.76
Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J (Clin Res Ed) (1981) 2.74
Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature (1992) 2.66
Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res (1985) 2.62
Theophylline prescribing, serum concentrations, and toxicity. Lancet (1983) 2.40
Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. Br Med J (Clin Res Ed) (1984) 2.19
Inhaled corticosteroids: benefits and risks. Thorax (1992) 2.17
Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur Respir J (1994) 2.07
Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med (1981) 1.94
Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1989) 1.81
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Thorax (1995) 1.72
Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol (2000) 1.71
alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet (1977) 1.70
Absorption of glycine and glycine peptides from the small intestine of the rat. Clin Sci (1968) 1.69
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
Pseudo-steroid resistant asthma. Thorax (1999) 1.67
Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J (2010) 1.65
Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am Rev Respir Dis (1990) 1.57
BOOP and COP. Thorax (1991) 1.57
Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet (1993) 1.55
Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J (2001) 1.55
Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism. Thorax (2008) 1.54
Collateral ventilation. Thorax (2006) 1.42
Nedocromil sodium workshop. Respir Med (1989) 1.38
Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med (1992) 1.37
Treating patients with asthma who are dependent on systemic steroids. BMJ (1989) 1.37
Bronchoscopic and percutaneous aspiration biopsy in the diagnosis of bronchial carcinoma cell type. Thorax (1982) 1.36
Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. Br J Cancer (1989) 1.32
Dihydrocodeine for breathlessness in "pink puffers". Br Med J (Clin Res Ed) (1983) 1.32
Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur Respir J (1990) 1.32
Airways obstruction in rheumatoid arthritis. Ann Rheum Dis (1979) 1.31
Newly diagnosed cystic fibrosis in middle and later life. Thorax (1985) 1.30
Fibreoptic bronchoscopy: effect of multiple bronchial biopsies on diagnostic yield in bronchial carcinoma. Thorax (1982) 1.27
Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis (1987) 1.23
Spinal cord compression in small cell lung cancer: a retrospective study of 610 patients. Br J Cancer (1989) 1.20
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1991) 1.19
Supplemental oxygen and exercise ability in chronic obstructive airways disease. Thorax (1988) 1.19
Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol (2005) 1.18
No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J (1993) 1.18
Airway surface pH in subjects with cystic fibrosis. Eur Respir J (2003) 1.15
Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet (1990) 1.14
Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. Hum Mol Genet (1993) 1.14
Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther (2007) 1.13
Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosis. Respir Med (1995) 1.13
Recurrence of recipient Langerhans' cell histiocytosis following bilateral lung transplantation. Thorax (1998) 1.11
High frequency oscillations improve nasal mucociliary transport. Lancet (1984) 1.08
Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax (2000) 1.08
Social consequences of brain or liver relapse in small cell carcinoma of the bronchus. Radiother Oncol (1985) 1.06
Pulmonary disease severity in men with deltaF508 cystic fibrosis and residual chloride secretion. Lancet (1999) 1.05
Effect of nitrazepam and flurazepam on the ventilatory response to carbon dioxide. Thorax (1976) 1.04
Reproducibility of dynamically represented acoustic lung images from healthy individuals. Thorax (2007) 1.03
Depression of central respiratory drive by nitrazepam. Thorax (1978) 1.03
Erythromycin and diffuse panbronchiolitis. Thorax (1997) 1.03
Dornase alfa for cystic fibrosis. Patients should not be denied a safe, effective treatment. BMJ (1995) 1.02
The effect of isoprenaline on plasma renin activity in man: a dose-response curve. Clin Endocrinol (Oxf) (1977) 1.01
Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy. Cancer Treat Rep (1982) 1.01
The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther (1999) 1.01
Self-administered home intravenous antibiotic therapy in bronchiectasis and adult cystic fibrosis. Lancet (1984) 1.01
Inhibition of exercise-induced asthma by an orally absorbed mast cell stabilizer (M & B 22,948). Br J Dis Chest (1983) 1.01
Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers. Thorax (1991) 0.99
Bronchoalveolar lavage in the diagnosis of diffuse pulmonary shadowing. Br J Dis Chest (1984) 0.98
Absence of electrochemical defect of cystic fibrosis in transplanted lung. Lancet (1987) 0.98
Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium. Gene Ther (2001) 0.98
Poly (D, L-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo. Gene Ther (2003) 0.97
Sarcoidosis in two patients with cystic fibrosis: a fortuitous association? Thorax (1987) 0.96
Measurement of nasal potential difference in adult cystic fibrosis, Young's syndrome, and bronchiectasis. Thorax (1987) 0.96
Cyclosporin as an oral corticosteroid sparing agent in stable asthma. Cochrane Database Syst Rev (2001) 0.96
Morphological and secretory properties of bronchoalveolar lavage mast cells in respiratory diseases. Clin Allergy (1986) 0.96
Allergic bronchopulmonary aspergillosis: a review. J R Soc Med (1992) 0.95
Unstable asthma and theophylline. BMJ (1991) 0.94
Role of CT in the management of pneumothorax in patients with complex cystic lung disease. Chest (1997) 0.94
Reduction in the adherence of Pseudomonas aeruginosa to native cystic fibrosis epithelium with anti-asialoGM1 antibody and neuraminidase inhibition. Eur Respir J (1999) 0.94
Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease. Thorax (1998) 0.93
The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects. Am J Respir Cell Mol Biol (1999) 0.93
Experience of totally implantable venous access devices (TIV ADs) in adults with cystic fibrosis over a 13-year period. Respir Med (2000) 0.93
Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Ther (2006) 0.93
Thoracoscopy: assessment of a physician service and comparison of a flexible bronchoscope used as a thoracoscope with a rigid thoracoscope. Thorax (1988) 0.92
Transepithelial potential difference in cystic fibrosis. Thorax (1985) 0.92
Anti-inflammatory gene therapy directed at the airway epithelium. Gene Ther (2000) 0.91
Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther (2007) 0.91
Fibreoptic bronchoscopy: effect of experience of operator on diagnostic yield of bronchial biopsy in bronchial carcinoma. Br J Dis Chest (1982) 0.90
Computed tomography and cystic fibrosis: promises and problems. Thorax (2007) 0.90
Home treatment of patients with cystic fibrosis using the 'Intermate': the first year's experience. J Adv Nurs (1995) 0.90
Inspiration-phased oxygen delivery. Lancet (1984) 0.90
Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth. Eur Respir J (1994) 0.90
Gene therapy progress and prospects: cystic fibrosis. Gene Ther (2006) 0.90
Gene therapy for cystic fibrosis. J Gene Med (2001) 0.89
The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Gene Ther (1998) 0.89
Distal intestinal obstruction syndrome in cystic fibrosis treated by oral intestinal lavage, and a case of recurrent obstruction despite normal pancreatic function. Thorax (1987) 0.89
Bioelectric characteristics of exon 10 insertional cystic fibrosis mouse: comparison with humans. Am J Physiol (1995) 0.89
CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium. Am J Respir Cell Mol Biol (1997) 0.88
Gene therapy progress and prospects: cystic fibrosis. Gene Ther (2002) 0.88
Characterization of a Ca(2+)-dependent anion channel from sheep tracheal epithelium incorporated into planar bilayers. J Physiol (1991) 0.88
Lung cancer: future prospects. Recent Results Cancer Res (1984) 0.88
A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Ther (2004) 0.87
Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteers. Gene Ther (1997) 0.87